Comparison of Resolute zotarolimus-eluting and Xience everolimus-eluting stents in patients with de novo long coronary artery lesions-Reference-Cited by-同舟云学术

Comparison of Resolute zotarolimus-eluting and Xience everolimus-eluting stents in patients with de novo long coronary artery lesions

Published:2019-01 Issue:1 Volume:30 Page:59-66
ISSN:0954-6928
Container-title:Coronary Artery Disease
language:en
Short-container-title:

Author:

Kang Do-Yoon,Lee Cheol Hyun,Lee Pil Hyung,Ahn Jung-Min,Lee Seung-Whan,Kim Young-Hak,Park Seong-Wook,Nam Chang Wook,Choi Yun Seok,Rha Seung-Woon,Cho Jang Hyun,Kim Weon,Her Sung-Ho,Jeong Myung Ho,Yang Joo-Young,Lee Bong-Ki,Park Hun Sik,Park Duk-Woo,Park Seung-Jung

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Cardiology and Cardiovascular Medicine,General Medicine

Reference27 articles.

1. Long-term safety of drug-eluting and bare-metal stents: evidence from a comprehensive network meta-analysis;Palmerini;J Am Coll Cardiol,2015

2. The relationship and threshold of stent length with regard to risk of stent thrombosis after drug-eluting stent implantation;Suh;JACC Cardiovasc Interv,2010

3. Impact of lesion length and vessel size on clinical outcomes after percutaneous coronary intervention with everolimus-versus paclitaxel-eluting stents pooled analysis from the SPIRIT (Clinical Evaluation of the XIENCE V Everolimus Eluting Coronary Stent System) and COMPARE (Second-generation everolimus-eluting and paclitaxel-eluting stents in real-life practice) Randomized Trials;Claessen;JACC Cardiovasc Interv,2011

4. Long-term predictors of clinical events after off-label use of drug-eluting stent beyond 1 year;Yun;Korean Circ J,2013

5. Angiographic and clinical outcomes of everolimus-eluting stent in the treatment of extra long stenoses (AEETES);Jim;J Interv Cardiol,2013

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Enhanced Reendothelialization and Thrombosis Prevention with a New Drug-Eluting Stent;Cardiovascular Drugs and Therapy;2024-06-04

2. Temporal Trends in the Outcomes of Percutaneous Coronary Intervention With Zotarolimus Eluting Stents Versus Everolimus Eluting Stents: A Meta‐Analysis of Randomized Controlled Trials;Clinical Cardiology;2024-06

3. Second-generation everolimus-eluting intracoronary stents: a comprehensive review of the clinical evidence;Future Cardiology;2024-01-31

4. A predictive model involving serum uric acid, C-reactive protein, diabetes, hypercholesteremia, multiple lesions for restenosis risk in everolimus-eluting stent-treated coronary heart disease patients;Frontiers in Cardiovascular Medicine;2022-08-11

5. Evaluation of Efficacy and Safety of Paclitaxel and Cilostazol Dual Drug-eluting Coronary Stents;Journal of Cardiovascular Intervention;2022